DexCom Shares Gain on Higher 4Q Revenue, Profit

Dow Jones

Feb 14

By Elias Schisgall

Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit.

The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months.

The glucose biosensing technology company after the close on Thursday reported a profit of $267.3 million, or 68 cents a share, compared with a profit of $151.7 million, or 38 cents a share, a year earlier.

Stripping out certain one-time items, the company's adjusted earnings also came in at 68 cents a share. Analysts surveyed by FactSet were expecting 65 cents a share.

Revenue grew 13% to $1.26 billion, up from $1.11 billion a year earlier. Analysts were expecting $1.25 billion.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 13, 2026 13:03 ET (18:03 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2611162999"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611162999\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611162999?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-14 02:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611162999","market":"sh","top_or_hot":-1,"title":"DexCom Shares Gain on Higher 4Q Revenue, Profit","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit. \n</p>\n<p>\n  The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months. \n</p>\n<p>\n  The glucose biosensing technology company after the close on Thursday reported a profit of $267.3 million, or 68 cents a share, compared with a profit of $151.7 million, or 38 cents a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company's adjusted earnings also came in at 68 cents a share. Analysts surveyed by FactSet were expecting 65 cents a share. \n</p>\n<p>\n  Revenue grew 13% to $1.26 billion, up from $1.11 billion a year earlier. Analysts were expecting $1.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 13:03 ET (18:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DexCom Shares Gain on Higher 4Q Revenue, Profit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexCom Shares Gain on Higher 4Q Revenue, Profit\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-02-14 02:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Elias Schisgall \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit. \n</p>\n<p>\n  The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months. \n</p>\n<p>\n  The glucose biosensing technology company after the close on Thursday reported a profit of $267.3 million, or 68 cents a share, compared with a profit of $151.7 million, or 38 cents a share, a year earlier. \n</p>\n<p>\n  Stripping out certain one-time items, the company's adjusted earnings also came in at 68 cents a share. Analysts surveyed by FactSet were expecting 65 cents a share. \n</p>\n<p>\n  Revenue grew 13% to $1.26 billion, up from $1.11 billion a year earlier. Analysts were expecting $1.25 billion. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 13, 2026 13:03 ET (18:03 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DXCM","symbol_name":"德康医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2611162999","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611162999","pubTimestamp":1771005780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit.The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months.The glucose biosensing technology company after the close on Thursday reported a profit of $267.3 million, or 68 cents a share, compared with a profit of $151.7 million, or 38 cents a share, a year earlier.Stripping out certain one-time items, the company's adjusted earnings also came in at 68 cents a share. Analysts surveyed by FactSet were expecting 65 cents a share.Revenue grew 13% to $1.26 billion, up from $1.11 billion a year earlier. Analysts were expecting $1.25 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"DXCM":"德康医疗"},"translate_title":"DexCom股价因第四季度收入和利润增加而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DXCM":1.5},"content_text":"By Elias Schisgall \n\n\n \n\n\n  Shares of DexCom rose after higher revenue in the fourth quarter boosted the company's profit. \n\n\n  The stock was up 9% to $70.96 in Friday afternoon trading. Shares have fallen 16% over the past 12 months. \n\n\n  The glucose biosensing technology company after the close on Thursday reported a profit of $267.3 million, or 68 cents a share, compared with a profit of $151.7 million, or 38 cents a share, a year earlier. \n\n\n  Stripping out certain one-time items, the company's adjusted earnings also came in at 68 cents a share. Analysts surveyed by FactSet were expecting 65 cents a share. \n\n\n  Revenue grew 13% to $1.26 billion, up from $1.11 billion a year earlier. Analysts were expecting $1.25 billion. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2026 13:03 ET (18:03 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}